CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies

Inactivating p53 mutations are the most abundant genetic alterations found in cancer. Here we show that CRISPR/Cas9-induced double-stranded DNA breaks enrich for cells deficient in p53 and in genes of a core CRISPR–p53 tumor suppressor interactome. Such enrichment could predispose to cancer developm...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Long, Ingelshed, Katrine, Shen, Yunbing, Boddul, Sanjaykumar V., Iyer, Vaishnavi Srinivasan, Kasza, Zsolt, Sedimbi, Saikiran, Lane, David P., Wermeling, Fredrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Genome and Epigenome
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397613/
https://www.ncbi.nlm.nih.gov/pubmed/34750099
http://dx.doi.org/10.1158/0008-5472.CAN-21-1692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397613/
https://www.ncbi.nlm.nih.gov/pubmed/34750099
http://dx.doi.org/10.1158/0008-5472.CAN-21-1692

Ejemplares similares